Sign in
4

Changes in Ownership

Cocrystal Pharma, Inc. Filed Acc 0001493152-22-021150

Options or other derivatives

  • Co- Interim CEO and CFO acquired 300,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Martin James Joseph Co- Interim CEO and CFO 2022-07-25 Grant or award · Stock Options (Right to Buy) +300,000 300,000 D: show line 1 in the form
Loading xslF345X03/ownership.xml…